4th Edition of International Heart Congress
June 22-24,2026 | Hybrid Event
Valvular Heart Disease
Valvular heart disease occurs when one or more of the heart's valves are damaged, affecting the normal flow of blood through the heart. This condition can involve valve stenosis (narrowing of the valve opening) or valve regurgitation (leakage of the valve), both of which can impair heart function over time. Common causes include age-related changes, infections like endocarditis, or congenital defects. Symptoms of valvular heart disease may include fatigue, shortness of breath, and swelling in the legs. Treatment options vary based on the severity of the condition and may include medications to control symptoms or surgical interventions such as valve repair or replacement. Early detection and management are key to preventing more severe complications.
Shuping Zhong
University of Southern California, United States
Ahdy Wadie Helmy
Indiana University School of Medicine, United States
Federico Benetti
Benetti Foundation, Argentina
Mekhman N Mamedov
National Research Center for Preventive Medicine, Russian Federation
Miroslav Radenkovic
University of Belgrade, Serbia
Syed Raza
Awali Hospital, Bahrain
Sergey Suchkov
N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian FederationSubmit your abstract Today
Title : Pharmacological advancement in pulmonary arterial hypertension treatment - Contribution of treprostinil dry-powder formulation
Miroslav Radenkovic, University of Belgrade, Serbia
Title : Personalized and Precision Medicine (PPM) and PPN-guided cardiology practice as a unique model via translational applications and upgraded business modeling to secure human healthcare, wellness and biosafety
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Cardiovascular nanomedicine: Stopping strokes, unclogging arteries and restoring heart function
Thomas J Webster, Hebei University of Technology, China
Title : Antibodies with functionality as a new generation of translational tools designed to monitor autoimmune myocarditis at clinical and subclinical stages
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Historical evolution from OPCAB to MIDCAB to mini OPCAB surgical technique and results
Federico Benetti, Benetti Foundation, Argentina
Title : Characterizing cardiac ECG and echocardiographic abnormalities in cirrhotic patients with and without heart failure
Ishan Abdullah, George Washington University School of Medicine and Health Sciences, United States